Biophytis SA American Depositary Share (BPTS)

Etorro trading 970x250

About Biophytis SA American Depositary Share

Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company’s lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France. Address: Sorbonne University, Paris, France, 75005

Biophytis SA American Depositary Share News and around…

Latest news about Biophytis SA American Depositary Share (BPTS) common stock and company :

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
10 Aug, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers as we check out the latest news for Wednesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
09 Aug, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

12 Health Care Stocks Moving In Monday's After-Market Session
08 Aug, 2022 FinancialContent

Gainers BIMI Intl Medical (NASDAQ:BIMI) stock moved upwards by 90.8% to $1.17 during Monday's after-market session. ...

12 Health Care Stocks Moving In Thursday's After-Market Session
21 Jul, 2022 FinancialContent

Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
20 Jul, 2022 FinancialContent

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The ...

This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
20 Jul, 2022 FinancialContent

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
06 Jul, 2022 FinancialContent

Gainers ThermoGenesis Holdings (NASDAQ:THMO) shares increased by 65.2% to $0.38 during Wednesday's regular session. ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
05 Jul, 2022 FinancialContent

Gainers Nuwellis (NASDAQ:NUWE) stock increased by 52.4% to $0.92 during Tuesday's regular session. Nuwellis's ...

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
01 Jul, 2022 FinancialContent

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday. Allena ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
01 Jul, 2022 FinancialContent

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 84.7% to $0.83 during Friday's pre-market session. ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
01 Jul, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.

Akebia Therapeutics And 20 Stocks Moving Premarket
01 Jul, 2022 FinancialContent

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on ...

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
01 Jul, 2022 FinancialContent

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. ...

Biophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for €4 Million
30 Jun, 2022 Yahoo! Finance

On June 14, 2021, Biophytis announced a convertible line of €32 million from Atlas. The financing instrument allows the issuance of 1,280 ORNANE, at a par value of €25,000 each.

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
30 Jun, 2022 FinancialContent

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation ...

Biophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress
27 Jun, 2022 FinancialContent

PARIS, FRANCE and CAMBRIDGE, MASSACHUSETTS / ACCESSWIRE / June 27, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes in patients suffering from age-related diseases, announced today that it is giving an oral presentation on the development of Sarconeos (BIO101) for the treatment of sarcopenia at the 15th International SCWD Congress (Society on Sarcopenia, Cachexia & Wasting disorders).

Biophytis: Results of the Combined General Meeting on June 21, 2022
22 Jun, 2022 Yahoo! Finance

Thanks to the mobilization of shareholders, the CGM could be held on second call with a quorum of more than 23% of the shareholders present or represented. The results of the votes of the combined General Meeting will be available on Biophytis' website from June 23, 2022, under the section - Investors - General Assembly.

12 Health Care Stocks Moving In Monday's Intraday Session
13 Jun, 2022 FinancialContent

Gainers Day One Biopharmaceutical (NASDAQ:DAWN) stock increased by 106.0% to $13.64 during Monday's regular session. ...

Biophytis: Convening of Another Combined General Meeting at a Later Date
03 Jun, 2022 FinancialContent

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 3, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19, informs its shareholders that the combined Annual General Meeting (AGM) held on June 3, 2022 was unable to deliberate, as the required quorum was not reached.

66 Biggest Movers From Friday
23 May, 2022 FinancialContent

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 ...

Stocks That Hit 52-Week Lows On Tuesday
17 May, 2022 FinancialContent

On Tuesday, 123 stocks made new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by ...

Biophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June
12 May, 2022 Yahoo! Finance

Biophytis' participation in BIO is aligned with the Company's strategy to partner with global or regional players to license and co-develop its core assets. More particularly, the Company is actively seeking partners to continue the development of Sarconeos (BIO101) in Phase 2/3 in Sarcopenia and to distribute the product in COVID-19-related respiratory failure if Phase 2/3 is successful and emergency use authorisation is granted.

53 Biggest Movers From Yesterday
21 Apr, 2022 FinancialContent

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded ...

Biophytis: Biophytis Presents Sarconeos (BIO101) Development Program in Sarcopenia at the 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston April 20-22, 2022
19 Apr, 2022 FinancialContent

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 19, 2022 / Biophytis SA ((NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19, today announces it will present and discuss the results of Sarconeos (BIO101) development program in Sarcopenia at the 12th annual International Conference on Frailty and Sarcopenia Research (ICFSR) to be held virtually and on site in Boston from April 20 to April 22, 2022.

12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Apr, 2022 FinancialContent

Gainers Alzamend Neuro (NASDAQ:ALZN) shares rose 19.6% to $1.22 during Tuesday's after-market session. Today's trading volume for ...

12 Health Care Stocks Moving In Thursday's Intraday Session
07 Apr, 2022 FinancialContent

Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi ...

38 Stocks Moving In Thursday's Mid-Day Session
07 Apr, 2022 FinancialContent

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
07 Apr, 2022 FinancialContent

Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their ...

Biophytis Shares Fall As It Stops Enrollment In Sarconeos COVID-19 Trial, Data Expected In Q3 2022
07 Apr, 2022 FinancialContent

Biophytis SA(NASDAQ: BPTS) said that it iscurrently assessing FDA comments and recommendationsand preparing to ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
07 Apr, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. 10 Stocks Are Issuing Sell Signals Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Biophytis SA American Depositary Share (BPTS) is a NASDAQ Common Stock listed in , ,

970x250